Results 121 to 130 of about 6,040 (212)

Targeting dysregulated CB1 receptors in a Down syndrome mouse model improves neurological outcomes. [PDF]

open access: yesAlzheimers Dement
Vázquez-Oliver A   +8 more
europepmc   +1 more source

Anti-inflammatory and analgesic potential of minor cannabinoids in vivo. [PDF]

open access: yesJ Cannabis Res
Vanegas SO   +4 more
europepmc   +1 more source

Pharmacokinetic and pharmacodynamic properties of cannabigerol in male mice. [PDF]

open access: yesJ Pharmacol Exp Ther
Mabou Tagne A   +10 more
europepmc   +1 more source

Rimonabant: una nueva perspectiva en el tratamiento de las conductas adictivas

open access: yes, 2006
Se revisa la farmacología, eficacia clínica, farmacocinética, seguridad y lugar en la terapéutica de rimonabant, un nuevo antagonista selectivo de los receptores cannabinoides CB1.Se realizó una revisión de la literatura primaria obtenida en el MEDLINE ...
Bellver, Maria   +3 more
core  

Modulatory Effects of CB1 Receptors on Cognitive Performance in Rat Model of Empathic Pain. [PDF]

open access: yesBasic Clin Neurosci
Rahimi Shourmasti F   +5 more
europepmc   +1 more source

Topical WIN 55 212-2 Confers Long-Term Intraocular Pressure-Independent Neuroprotection in the DBA/2J Mouse Model of Glaucoma. [PDF]

open access: yesOphthalmol Sci
Gallo Afflitto G   +8 more
europepmc   +1 more source

Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models. [PDF]

open access: yesCurr Top Behav Neurosci
Bedillion MF   +5 more
europepmc   +1 more source

Diet-dependent modulation of energy balance by CB1 signaling in peripheral sensory neurons. [PDF]

open access: yesiScience
Linden B   +15 more
europepmc   +1 more source

Brain Hsp90 Inhibition Mitigates Facial Allodynia in a Rat Model of CSD Headache and Upregulates Endocannabinoid Signaling in the PAG. [PDF]

open access: yesPharmaceuticals (Basel)
Palomino SM   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy